AARDEX Group is dedicated to staying at the forefront of industry knowledge and expertise. That's why we regularly attend industry events and host webinars featuring top-tier experts in medication adherence. These webinars provide valuable insights and give attendees a front-row seat to the latest industry trends and developments.
LEARN WITH AARDEX GROUP
We are excited to offer on-demand and upcoming webinars focused on medication adherence. Our webinars feature industry-leading experts who provide actionable insights and strategies to improve medication adherence and ultimately, patient outcomes. Whether you are a healthcare provider, researcher, or patient, our webinars offer invaluable information and resources to help you better understand medication adherence and its importance in healthcare. Don't miss out on this opportunity to learn from the best in the field and stay up-to-date on the latest advancements in medication adherence. Register now for our upcoming webinars or access our on-demand webinars at any time.
Rebecca Beck, BD, Bernard Vrijens, AARDEX Group, and Arnaud Guillet, Biocorp
Job Van Boven, Associate Professor, University Medical Center Groningen, and Bernard Vrijens, Scientific Lead, AARDEX Group
Matt Bolton of Merck and Ning Yu of Biogen
Ken Kaitin, TUFTS, John Musaus, Thermo Fisher and Timothy Peters-Strickland, PPD
WHERE TO FIND US NEXT
Our medication adherence experts are on a mission to change the game in clinical trials. They'll be taking our message to the people at several upcoming conferences. If you're ready to join the movement and revolutionize your approach to adherence in clinical trials, be sure to catch us at one of these events.
June 26-28, 2024, Tokyo, Japan
July 8, 2024, 6:30-8:30pm, Boston Mariott Burlington, USA
July 9-10, 2024, Boston, USA
August 30, 2024, Brussels, Belgium
November 10-13, 2024, Boston, USA
November 21-23, 2024, Naples, Italy
IN CONVERSATION WITH MERCK & BIOGEN
Mitigating the Risk of Poor Adherence in Trials
Watch this live recording with adherence experts from Merck & Biogen to learn about their approach to mitigating the risk of poor adherence in trials.
FROM THE AARDEX GROUP BLOG
We are thrilled to feature expert insights from Bernard Vrijens, a world-renowned expert on medication adherence. Taking medication as prescribed is crucial to achieving optimal health outcomes, yet non-adherence is a prevalent issue. Bernard Vrijens' extensive research and experience in the field provide invaluable insights into the factors that contribute to medication non-adherence and effective strategies to address them. His contributions to our medication adherence blog offer actionable advice and evidence-based recommendations to improve medication adherence and ultimately, patient outcomes.
Clearly it is in no one’s interests for a clinical trial to fail. Whenever these high-stake activites are abandoned and drug development pathways are aborted, missed opportunities abound. Beyond the sponsor’s missed commercial opportunity, there are missed opportunities to advance
In a clinical trial, every piece of data contributes to the overall story being told. No matter how small or seemingly insignificant, all the information that emerges over the course of the process adds rich detail to the narrative. Two
AARDEX Group Belgium – SHL Medical, a world-leading provider of drug delivery devices, and AARDEX Group, the global leader in medication adherence solutions, today announced their strategic partnership aimed at delivering an end-to-end solution for pharma customers seeking to demonstrate
It is perhaps ironic that Alexander Graham Bell, often singled out as the individual who invented the telephone, was a man who believed in the value of collective endeavour. Indeed, Bell is quoted as saying: “Great discoveries and improvements invariably
In 1920, The Lancet published a paper authored by T.C. Graves entitled ‘Commentary on a case of hystero-epilepsy with delayed puberty: Treated with testicular extract’. While the article was not the first to mention the placebo effect, it is recognised
Among the many forces that can influence clinical trials, arguably not enough attention is paid to status quo bias. A common phenomenon, status quo bias can explain why any proposed departure from existing expectations or dominant practice can be